Inventor

BERDINI VALERIO

GB45 patents

⚠️ This page may combine multiple inventors who share the name “BERDINI VALERIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BERDINI VALERIO

ASTEX THERAPEUTICS LTD

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

Pteridines as FGFR inhibitors

Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors

Substituted quinoxalines as FGFR kinase inhibitors

Pyrazolyl quinoxaline kinase inhibitors

Quinolines as FGFR kinase modulators

Benzimidazole derivatives and their use as protein kinase inhibitors

Pyrazolyl quinoxaline kinase inhibitors

Substituted quinoxalines as FGFR kinase inhibitors

Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors

Quinolines as FGFR kinase modulators

Pyrazolyl quinoxaline kinase inhibitors

Substituted quinoxalines as FGFR kinase inhibitors

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

Pteridines as FGFR inhibitors

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein

Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

Pyrazole derivatives as protein kinase modulators

BERDINI VALERIO

Pharmaceutical compounds

Bicyclic heterocyclic compounds as FGFR inhibitors

Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases

Imidazo[1,2-a]pyridine compounds for use in treating cancer

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

Pyrazole derivatives as protein kinase modulators

Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors

Pyrazole derivatives as protein kinase modulators

Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases

SAXTY GORDON

Substituted quinoxalines as FGFR kinase inhibitors

Pyrazolyl quinoxaline kinase inhibitors

Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors

FGFR pharmacophore compounds

Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors

Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors

Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use

Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors

Imidazo [1,2-A]pyridine derivatives as FGFR kinase inhibitors for use in therapy

OTSUKA PHARMA CO LTD

Benzolactam compounds as protein kinase inhibitors

Benzolactam compounds as protein kinase inhibitors

Benzolactam compounds as protein kinase inhibitors

DOMPÉ S P A

Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells

ALLEGRETTI MARCELLO

Omega aminoalkylamides of R-2 aryl propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells